Nevro Corp. buy Royal Bank of Canada
Start price
01.12.23
/
50%
€17.20
Target price
01.12.24
€21.13
Performance (%)
-74.42%
Price
04.10.24
€4.40
Summary
This prediction is currently active. Massive losses of -74.42% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 01.12.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Nevro Corp. | -4.348% | -4.348% |
iShares Core DAX® | -1.114% | 5.062% |
iShares Nasdaq 100 | 1.816% | 9.828% |
iShares Nikkei 225® | 2.113% | 8.218% |
iShares S&P 500 | 2.038% | 7.448% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Nevro Corp. diskutieren
Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.
Ratings data for NVRO provided by MarketBeat